Literature DB >> 32755215

VI-RADS: Multiinstitutional Multireader Diagnostic Accuracy and Interobserver Agreement Study.

Yoshiko Ueno1, Tsutomu Tamada1,2, Mitsuru Takeuchi1,3, Keitaro Sofue1, Satoru Takahashi1,4, Yuki Kamishima1,5, Yasuyo Urase1, Ayumu Kido2, Nobuyuki Hinata6, Kenichi Harada6, Masato Fujisawa6, Yoshiyuki Miyaji7, Takamichi Murakami1.   

Abstract

BACKGROUND. The Vesical Imaging Reporting and Data System (VI-RADS), based on multiparametric MRI (mpMRI), was developed to provide accurate information for the diagnosis of muscle-invasive bladder cancer (MIBC). OBJECTIVE. The purpose of our study was to evaluate the interobserver agreement and diagnostic performance of VI-RADS among readers with different levels of experience. METHODS. This retrospective study included 91 consecutive patients who underwent mpMRI before transurethral resection of bladder tumor (TURBT) from July 2010 through August 2018. After attending a training session, seven radiologists (five radiologists experienced in bladder MRI and two inexperienced radiologists) reviewed and scored all MRI examinations according to VI-RADS. The interobserver agreement was assessed by kappa statistics. ROC analysis was used to evaluate the diagnostic performance for MIBC. AUCs were estimated. RESULTS. Among 91 patients (72 men and 19 women; mean age ± SD, 73.2 ± 10.2 years), 48 (52.7%) had MIBC and 43 (47.3%) had non-muscle-invasive bladder cancer. Sixty-eight patients were treated with TURBT, and 23 were treated with radical cystectomy. Interobserver agreement was moderate to substantial (κ = 0.60-0.80) among the experienced readers, substantial (κ = 0.67) between the two inexperienced readers, and moderate to substantial (κ = 0.55-0.75) between the experienced and inexperienced readers. The pooled AUC was 0.88 (range, 0.82-0.91) for experienced readers and 0.84 (range, 0.83-0.85) for inexperienced readers, and 0.87 for all readers. Using a VI-RADS score of 4 or greater as the cutoff value for MIBC, the pooled sensitivity and specificity were 74.1% (range, 66.0-80.9%) and 94.1% (range, 88.6-97.7%) for experienced readers and 63.9% (range, 59.6-68.1%) and 86.4% (range, 84.1-88.6%) for inexperienced readers. Using a VI-RADS score of 3 or greater as the cutoff value, the pooled sensitivity and specificity were 83.4% (range, 80.9-85.1%) and 77.3% (range, 61.4-88.6%) for experienced readers and 82.0% (range, 80.9-83.0%) and 73.9% (range, 72.7-75.0%) for inexperienced readers. CONCLUSION. We observed moderate to substantial interobserver agreement and a pooled AUC of 0.87 among radiologists of different levels of expertise using VI-RADS. CLINICAL IMPACT. VI-RADS could help determine the depth and range of excision in TURBT, decreasing the risk of complications and enhancing the accuracy of pathologic diagnosis.

Entities:  

Keywords:  bladder cancer; diffusion-weighted MRI; multiparametric MRI; neoplasm grading; neoplasm staging

Year:  2020        PMID: 32755215     DOI: 10.2214/AJR.20.23604

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  8 in total

Review 1.  Multiparametric magnetic resonance imaging for bladder cancer: a comprehensive systematic review of the Vesical Imaging-Reporting and Data System (VI-RADS) performance and potential clinical applications.

Authors:  Denis Séguier; Philippe Puech; Ronald Kool; Léa Dernis; Héléna Gabert; Wassim Kassouf; Arnauld Villers; Gautier Marcq
Journal:  Ther Adv Urol       Date:  2021-08-25

2.  Diagnostic accuracy of vesical imaging-reporting and data system (VI-RADS) for the detection of muscle-invasive bladder cancer: a meta-analysis.

Authors:  Yuebo Feng; Kai Zhong; Rui Chen; Weibin Zhou
Journal:  Abdom Radiol (NY)       Date:  2022-02-18

Review 3.  Recurrence mechanisms of non-muscle-invasive bladder cancer - a clinical perspective.

Authors:  Jeremy Yuen-Chun Teoh; Ashish M Kamat; Peter C Black; Petros Grivas; Shahrokh F Shariat; Marek Babjuk
Journal:  Nat Rev Urol       Date:  2022-03-31       Impact factor: 16.430

Review 4.  The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations.

Authors:  Francesco Del Giudice; Rocco Simone Flammia; Martina Pecoraro; Marco Moschini; David D'Andrea; Emanuele Messina; Lucia Martina Pisciotti; Ettore De Berardinis; Alessandro Sciarra; Valeria Panebianco
Journal:  World J Urol       Date:  2022-03-16       Impact factor: 3.661

Review 5.  The Role of Imaging in Bladder Cancer Diagnosis and Staging.

Authors:  Samuel J Galgano; Kristin K Porter; Constantine Burgan; Soroush Rais-Bahrami
Journal:  Diagnostics (Basel)       Date:  2020-09-16

6.  The learning curve in bladder MRI using VI-RADS assessment score during an interactive dedicated training program.

Authors:  Miguel Correia da Silva; Martina Pecoraro; Martina Lucia Pisciotti; Ailin Dehghanpour; Ali Forookhi; Sara Lucciola; Marco Bicchetti; Emanuele Messina; Carlo Catalano; Valeria Panebianco
Journal:  Eur Radiol       Date:  2022-04-02       Impact factor: 7.034

7.  A novel pathway to detect muscle-invasive bladder cancer based on integrated clinical features and VI-RADS score on MRI: results of a prospective multicenter study.

Authors:  Marco Bicchetti; Giuseppe Simone; Gianluca Giannarini; Rossano Girometti; Alberto Briganti; Eugenio Brunocilla; Gianpiero Cardone; Francesco De Cobelli; Caterina Gaudiano; Francesco Del Giudice; Simone Flammia; Costantino Leonardo; Martina Pecoraro; Riccardo Schiavina; Carlo Catalano; Valeria Panebianco
Journal:  Radiol Med       Date:  2022-06-28       Impact factor: 6.313

Review 8.  VI-RADS score system - A primer for urologists.

Authors:  Refky Nicola; Martina Pecoraro; Sara Lucciola; Rodolfo Borges Dos Reis; Yoshifumi Narumi; Valeria Panebianco; Valdair Francisco Muglia
Journal:  Int Braz J Urol       Date:  2022 Jul-Aug       Impact factor: 3.050

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.